Top Markets
Coin of the day
Regenicin, Inc. Regenicin, Inc.

Regenicin, Inc.

RGIN
Clasificación en acciones #41590
Regenicin, Inc. is dedicated to the development and commercialization of... Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$15.35K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Regenicin, Inc. (RGIN)

Categoría

Ratio P/B de Regenicin, Inc. (RGIN)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Regenicin, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Regenicin, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE